Skip to content

Preventing High Pregnancy Blood Sugar with Yoga

Effectiveness of Antenatal Yoga for Prevention of GDM and improving fetomaternal outcomes in High-Risk Pregnant Women: A Randomized Controlled Trial - SHAPE

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107869
Enrollment
1174
Registered
2026-04-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O244- Gestational diabetes mellitus

Interventions

Intervention1: Adjunct Yoga: The intervention will be delivered alongside standard antenatal care, comprising 3-5 weekly 45-minute supervised group sessions (6-10 women/cohort) plus daily 20-30 minute

Sponsors

Dr Vijaya Majumdar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants must meet all of the following baseline criteria and at least one GDM-risk factor adapted for Asian women per DIPSI and Indian guidelines Baseline Requirements -Gestational age less than or equal to 16 weeks -Singleton pregnancy GDM-Risk Criteria (at least one required): -Screening BMI more than or equal to 23 kg/m (Asian cutoff) -Maternal age more than or equal to 25 years -First-degree relative with diabetes -Previous pregnancy complicated by GDM -Previous delivery of large-for-gestational-age infant -Prior pregnancy with pre-eclampsia or eclampsia -History of polycystic ovarian syndrome (PCOS) or impaired fasting glucose Medication and Treatment Criteria Not currently receiving any medications, except the following permitted treatments -Iron, calcium, or folic acid supplements -Thyroxine for documented hypothyroidism For teleyoga -Stable pregnancy (no active complications: bleeding, contractions, PROM) -Pre-tele-yoga assessment: Normal BP (less than 140/90) -Family support: Adult present during first 3 sessions -Smartphone/tablet/laptop with front-facing camera

Exclusion criteria

Exclusion criteria: -GDM at screening -Pre-existing diabetes (Type 1, TYpe 2, monogenic or secondary) -Multiple pregnancy (twins, triplets, etc) -Medical contraindications to yoga or exercise -Acute shock or sepsis at recruitment -Known major fetal anomaly or estimated fetal weight less than 10th percentile -Current gestational hypertension, preeclampsia, or ruptured membranes -Substance abuse (drugs/alcohol) impairing study adherence -Severe gastrointestinal disorders Special Provision for Fertility Treatments: Women who conceived following ovulation induction with clomiphene citrate or metformin for PCOS will not be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Incidence of gestational diabetes mellitus (GDM) at 26 28 weeks of gestation, diagnosed using a 75 g oral glucose tolerance test (OGTT) and IADPSG criteria. Maternal outcomes (assessed at 26 28 weeks, 32 weeks, at delivery, and approximately. 3 months postpartum, as applicable -Fasting and 2-hour post-load plasma glucose, where feasible, HbA1c and fasting insulin -Total gestational weight gain and change in BMI -Blood pressure at each visit, and incidence of gestational hypertension and pre-eclampsia -Mode of delivery (spontaneous vaginal, assisted, caesarean), induction of labour, and intrapartum complications -Post-partum depression (3 months), maternal quality of life, and perceived stress using validated scales. Fetal outcomes -Birthweight, low birth weight, macrosomia, preterm birth, and stillbirth. -Neonatal anthropometryTimepoint: 24-26 weeks of gestation

Secondary

MeasureTime frame
Maternal outcomes (assessed at -Fasting and 2-hour post-load plasma glucose, where feasible, HbA1c and fasting insulin -Total gestational weight gain and change in BMI -Blood pressure at each visit, and incidence of gestational hypertension and pre-eclampsia -Mode of delivery (spontaneous vaginal, assisted, caesarean), induction of labour, and intrapartum complications -Post-partum depression (3 months), maternal quality of life, and perceived stress using validated scales. Timepoint: 26 28 weeks, 32 weeks, at delivery, and approximately. 3 months postpartum, as applicable;Fetal outcomes -Birthweight, low birth weight, macrosomia, preterm birth, and stillbirth. -Neonatal anthropometry -NICU stay and combined adverse neonatal events (hypoglycaemia, respiratorydistress, sepsis, or invasive ventilationTimepoint: At delivery;Mechanistic outcomes (nested sub-study) transcriptomic profiling of maternal bloodTimepoint: Baseline and 26 28 weeks

Countries

India

Contacts

Public ContactDr Vijaya Majumdar

Swami Vivekananda Yoga Anusandhana S

majumdar.vijaya@gmail.com9036800821

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026